Pages that link to "Q35096396"
Jump to navigation
Jump to search
The following pages link to Improving DNA vaccine potency via modification of professional antigen presenting cells. (Q35096396):
Displaying 30 items.
- Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects (Q21284428) (← links)
- Antigen-specific immunotherapy of cervical and ovarian cancer (Q27488697) (← links)
- Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination (Q28236770) (← links)
- Characterization of HLA-A2-restricted HPV-16 E7-specific CD8( ) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice (Q30430626) (← links)
- Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA. (Q33778143) (← links)
- Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination (Q33864400) (← links)
- Perspectives for preventive and therapeutic HPV vaccines (Q34011494) (← links)
- Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potency (Q34015916) (← links)
- Immunotherapy for cervical cancer: Research status and clinical potential (Q34033763) (← links)
- Perspective for prophylaxis and treatment of cervical cancer: an immunological approach. (Q34181909) (← links)
- Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer (Q34544154) (← links)
- Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines (Q34708423) (← links)
- Role of IL-2 secreted by PADRE-specific CD4 T cells in enhancing E7-specific CD8 T-cell immune responses (Q34732491) (← links)
- Pretreatment with cisplatin enhances E7-specific CD8 T-Cell-mediated antitumor immunity induced by DNA vaccination (Q34732544) (← links)
- Enhancement of CD4 T-cell help reverses the doxorubicin-induced suppression of antigen-specific immune responses in vaccinated mice (Q34766642) (← links)
- Treatment With mANT2 shRNA Enhances Antitumor Therapeutic Effects Induced by MUC1 DNA Vaccination (Q34994496) (← links)
- DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4 T-cell immune responses and enhances vaccine potency (Q35210348) (← links)
- Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope (Q35230184) (← links)
- Epigallocatechin-3-gallate enhances CD8 T cell-mediated antitumor immunity induced by DNA vaccination. (Q35234948) (← links)
- DNA vaccines for cervical cancer: from bench to bedside (Q35234992) (← links)
- Control of human mesothelin-expressing tumors by DNA vaccines (Q35238497) (← links)
- Innovative DNA vaccine to break immune tolerance against tumor self-antigen (Q36634823) (← links)
- Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6. (Q36684369) (← links)
- Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8 T-cell-mediated antitumor immunity induced by DNA vaccination (Q36874310) (← links)
- Multifunctional nanorods for biomedical applications. (Q36904536) (← links)
- Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects (Q37038302) (← links)
- Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus (Q37423250) (← links)
- Therapeutic vaccines for high-risk HPV-associated diseases. (Q47255618) (← links)
- Therapeutic human papillomavirus vaccines: current clinical trials and future directions (Q56937332) (← links)
- Therapeutic HPV DNA vaccines (Q84504653) (← links)